Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Romiplostim safe and effective in phase I/II study in pediatric ITP patients

Dec. 17, 2009

Final data reported from phase Ib trial of atacicept in pretreated CLL patients

Dec. 17, 2009

Beneficial effects of SUN-11031 in COPD patients with cachexia reported

Dec. 16, 2009

Studies find benefit with intravitreal dexamethasone implant in ocular indications

Dec. 16, 2009

Pharmacyclics presents phase I data on lymphoma agents

Dec. 16, 2009

Novel proteasome inhibitor NPI-0052 shows safety in phase I trials

Dec. 16, 2009

Tenecteplase restores function to occluded central venous catheters

Dec. 16, 2009

CALISTO trial reveals efficacy of fondaparinux in treating superficial vein thrombosis

Dec. 15, 2009

Phase I data reported for terameprocol in patients with advanced leukemias

Dec. 15, 2009

GMI-1070 shows safety and tolerability in phase I trial in healthy subjects

Dec. 15, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...